Ident. | Authors (with country if any) | Title |
---|
000064 (2011-03-15) |
Ana Budimir [Croatie] | Metal ions, Alzheimer's disease and chelation therapy |
000144 (2011) |
Nick Miller [Royaume-Uni] ; Emma Noble [Royaume-Uni] ; Diana Jones [Royaume-Uni] ; Katherine H. O. Deane [Royaume-Uni] ; Catherine Gibb [Royaume-Uni] | Survey of speech and language therapy provision for people with Parkinson's disease in the United Kingdom: patients' and carers' perspectives |
000232 (2011) |
Nick Miller [Royaume-Uni] ; Katherine H. O. Deane [Royaume-Uni] ; Diana Jones [Royaume-Uni] ; Emma Noble [Royaume-Uni] ; Catherine Gibb [Royaume-Uni] | National survey of speech and language therapy provision for people with Parkinson's disease in the United Kingdom: therapists’ practices |
000291 (2011) |
Polly Ambermoon [Australie] ; Adrian Carter [Australie] ; Wayne D. Hall [Australie] ; Nadeeka N. W. Dissanayaka [Australie] ; John D. O'Sullivan [Australie] | Impulse control disorders in patients with Parkinson's disease receiving dopamine replacement therapy: evidence and implications for the addictions field |
000328 (2011) |
F. Stocchi [Italie] ; J. M. Rabey [Israël] | Effect of rasagiline as adjunct therapy to levodopa on severity of OFF in Parkinson’s disease |
000377 (2011) |
Siegmund Winter [Autriche] ; Christian Meyer [Autriche, Allemagne] ; Martin Martinek [Autriche] ; Helmut Pürerfellner [Autriche] ; Hans Joachim Nesser [Autriche] | Cardiac Resynchronization Therapy by Ablation of Right‐Anterolateral Accessory Pathway |
000385 (2011) |
Raymond T. Bartus [États-Unis] ; Christopher D. Herzog [États-Unis] ; Yaping Chu [États-Unis] ; Alistair Wilson [États-Unis] ; Lamar Brown [États-Unis] ; Joao Siffert [États-Unis] ; Eugene M. Johnson Jr. [États-Unis] ; C. Warren Olanow [États-Unis] ; Elliott J. Mufson [États-Unis] ; Jeffrey H. Kordower [États-Unis] | Bioactivity of AAV2‐neurturin gene therapy (CERE‐120): Differences between Parkinson's disease and nonhuman primate brains |
000633 (2010) |
Shalini Narayana [États-Unis] ; Peter T. Fox [États-Unis] ; Wei Zhang [États-Unis] ; Crystal Franklin [États-Unis] ; Donald A. Robin [États-Unis] ; Deanie Vogel [États-Unis] ; Lorraine O. Ramig [États-Unis] | Neural correlates of efficacy of voice therapy in Parkinson's disease identified by performance–correlation analysis |
000643 (2010) |
Richard Dodel [Allemagne] ; Annika Spottke [Allemagne] ; Alexander Gerhard [Royaume-Uni] ; Alexander Reuss [Allemagne] ; Sylvia Reinecker [Allemagne] ; Nicole Schimke [Allemagne] ; Claudia Trenkwalder [Allemagne] ; Friederike Sixel-Döring [Allemagne] ; Birgit Herting [Allemagne] ; Christoph Kamm [Allemagne] ; Thomas Gasser [Allemagne] ; Martin Sawires [Autriche] ; Felix Geser [Autriche] ; Martin Köllensperger [Autriche] ; Klaus Seppi [Autriche] ; Manja Kloss [Allemagne] ; Martin Krause [Allemagne] ; Christine Daniels [Allemagne] ; Günther Deuschl [Allemagne] ; Silke Böttger [Allemagne] ; Markus Naumann [Allemagne] ; Axel Lipp [Royaume-Uni] ; Doreen Gruber [Allemagne] ; Andreas Kupsch [Allemagne] ; Yansheng Du [États-Unis] ; Federico Turkheimer [Royaume-Uni] ; David J. Brooks [Royaume-Uni] ; Thomas Klockgether [Allemagne] ; Werner Poewe [Autriche] ; Gregor Wenning [Autriche] ; Carmen Schade-Brittinger [Allemagne] ; Wolfgang H. Oertel [Allemagne] ; Karla Eggert [Allemagne] | Minocycline 1‐year therapy in multiple‐system‐atrophy: Effect on clinical symptoms and [11C] (R)‐PK11195 PET (MEMSA‐trial) |
000668 (2010) |
Fabrizio Stocchi [Italie] ; Olivier Rascol [France] ; Karl Kieburtz [États-Unis] ; Werner Poewe [Autriche] ; Joseph Jankovic [États-Unis] ; Eduardo Tolosa [Espagne] ; Paulo Barone [Italie] ; Anthony E. Lang [Canada] ; C. Warren Olanow [Italie, États-Unis] | Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: The STRIDE‐PD study |
000692 (2010) |
Seung Hun Lee [Corée du Sud] ; Mi Jung Kim [Corée du Sud] ; Beom-Jun Kim [Corée du Sud] ; Sung Reul Kim [Corée du Sud] ; Sail Chun [Corée du Sud] ; Jin Sook Ryu [Corée du Sud] ; Ghi Su Kim [Corée du Sud] ; Myoung Chong Lee [Corée du Sud] ; Jung-Min Koh [Corée du Sud] ; Sun Ju Chung [Corée du Sud] | Homocysteine‐lowering therapy or antioxidant therapy for bone loss in Parkinson's disease |
000694 (2010) |
Yutaka Naito [Japon] ; Ko Matsuo [Japon] ; Yasumasa Kokubo [Japon] ; Yugo Narita [Japon] ; Hidekazu Tomimoto [Japon] | Higher‐dose glutathione therapy for Parkinson's disease in Japan: Is it really safe? |
000706 (2010) |
Tomas Bjorklund [Suède] ; Jeffrey H. Kordower [États-Unis] | Gene therapy for Parkinson's disease |
000758 (2010) |
C. Tai ; R. Wu ; C. Lin ; M. Pan ; Y. Chen ; H. Liu ; H. Lu ; C. Tsai ; S. Tseng [Taïwan] | Deep brain stimulation therapy for Parkinson’s disease using frameless stereotaxy: comparison with frame‐based surgery |
000770 (2010) |
Andrew H. Evans [Australie, Royaume-Uni] ; Andrew D. Lawrence [Royaume-Uni] ; Silke Appel Cresswell [Canada] ; Regina Katzenschlager [Royaume-Uni, Autriche] ; Andrew Lees (neurologue) [Royaume-Uni] | Compulsive use of dopaminergic drug therapy in Parkinson's disease: Reward and anti‐reward |
000841 (2010) |
Barry J. Snow [Nouvelle-Zélande] ; Fiona L. Rolfe [Nouvelle-Zélande] ; Michelle M. Lockhart [Nouvelle-Zélande] ; Christopher M. Frampton [Nouvelle-Zélande] ; John D. O'Sullivan [Australie] ; Victor Fung [Australie] ; Robin A. J. Smith [Nouvelle-Zélande] ; Michael P. Murphy [Royaume-Uni] ; Kenneth M. Taylor [Nouvelle-Zélande] | A double‐blind, placebo‐controlled study to assess the mitochondria‐targeted antioxidant MitoQ as a disease‐modifying therapy in Parkinson's disease |
000943 (2009) |
Andrew Beenken [États-Unis] ; Moosa Mohammadi [États-Unis] | The FGF family: biology, pathophysiology and therapy |
000956 (2009) |
Seung U. Kim [Canada, Corée du Sud] ; Jean De Vellis [États-Unis] | Stem cell‐based cell therapy in neurological diseases: A review |
000974 (2009) |
Giuseppe Frazzitta [Italie] ; Roberto Maestri [Italie] ; Davide Uccellini [Italie] ; Gabriella Bertotti [Italie] ; Paola Abelli [Italie] | Rehabilitation treatment of gait in patients with Parkinson's disease with freezing: A comparison between two physical therapy protocols using visual and auditory cues with or without treadmill training |
000992 (2009) |
Samyra H. J. Keus [Pays-Bas] ; Marten Munneke [Pays-Bas] ; Maarten J. Nijkrake [Pays-Bas] ; Gert Kwakkel [Pays-Bas] ; Bastiaan R. Bloem [Pays-Bas] | Physical therapy in Parkinson's disease: Evolution and future challenges |
000A36 (2009) |
Shigeki Hirano [États-Unis, Japon] ; Thomas Eckert [États-Unis, Allemagne] ; Toni Flanagan [États-Unis] ; David Eidelberg [États-Unis] | Metabolic networks for assessment of therapy and diagnosis in Parkinson's disease |